Characterisation of neurons derived from a cortical human neural stem cell line CTX0E16 by Anderson, Greg W. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1186/s13287-015-0136-8
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Anderson, G. W., Deans, P. J. M., Taylor, R., Raval, P., Chen, D., Lowder, H., ... Srivastava, D. P. (2015).
Characterisation of neurons derived from a cortical human neural stem cell line CTX0E16. Stem cell research &
therapy, 6(1), [149]. 10.1186/s13287-015-0136-8
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
RESEARCH Open Access
Characterisation of neurons derived from a
cortical human neural stem cell line CTX0E16
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Srishti Murkerji1, Laura C. Andreae2, Brenda P. Williams1* and Deepak P. Srivastava1*
Abstract
Introduction: Conditionally immortalised human neural progenitor cells (hNPCs) represent a robust source of
native neural cells to investigate physiological mechanisms in both health and disease. However, in order to
recognise the utility of such cells, it is critical to determine whether they retain characteristics of their tissue of
origin and generate appropriate neural cell types upon differentiation. To this end, we have characterised the
conditionally immortalised, cortically-derived, human NPC line, CTX0E16, investigating the molecular and cellular
phenotype of differentiated neurons to determine whether they possess characteristics of cortical glutamatergic
neurons.
Methods: Differentiated CTX0E16 cells were characterised by assessing expression of several neural fates markers,
and examination of developing neuronal morphology. Expression of neurotransmitter receptors, signalling proteins
and related proteins were assessed by q- and RT-PCR and complemented by Ca2+ imaging, electrophysiology and
assessment of ERK signalling in response to neurotransmitter ligand application. Finally, differentiated neurons were
assessed for their ability to form putative synapses and to respond to activity-dependent stimulation.
Results: Differentiation of CTX0E16 hNPCs predominately resulted in the generation of neurons expressing markers
of cortical and glutamatergic (excitatory) fate, and with a typical polarized neuronal morphology. Gene expression
analysis confirmed an upregulation in the expression of cortical, glutamatergic and signalling proteins following
differentiation. CTX0E16 neurons demonstrated Ca2+ and ERK1/2 responses following exogenous neurotransmitter
application, and after 6 weeks displayed spontaneous Ca2+ transients and electrophysiological properties consistent
with that of immature neurons. Differentiated CTX0E16 neurons also expressed a range of pre- and post-synaptic
proteins that co-localized along distal dendrites, and moreover, displayed structural plasticity in response to
modulation of neuronal activity.
Conclusions: Taken together, these findings demonstrate that the CTX0E16 hNPC line is a robust source of cortical
neurons, which display functional properties consistent with a glutamatergic phenotype. Thus CTX0E16 neurons can
be used to study cortical cell function, and furthermore, as these neurons express a range of disease-associated
genes, they represent an ideal platform with which to investigate neurodevelopmental mechanisms in native
human cells in health and disease.
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Introduction
In the past decade, advances in stem cell biology have led
to the emergence of novel powerful tools to investigate
complex questions in neurobiology. Human neural stem
cells (hNSCs) and the neural progenitor cells (NPCs) that
they generate have become a major focus of interest as they
provide a renewable and accessible model system in which
to investigate basic human neurodevelopment mechanisms
and complex neurodevelopmental disorders [1–4]. One
major advantage of hNPCs is that they can easily undergo
biochemical, pharmacological and genetic manipulations,
making them an ideal platform for high-throughput, gen-
etic or small molecule functional screening [1–3, 5, 6].
Human NSCs and NPCs have been derived from numer-
ous stem cell types, including embryonic, fetal and adult
stem cells [7–10]. Previous studies have demonstrated that
hNPCs are self-renewing and are multipotent, being able
to differentiate into multiple neural cell types, including
different types of neurons, astroctyes and oligodendrocytes
[11–14]. Many groups have successfully generated neurons
characteristic of different neural tissues, including spinal
motor neurons, spinal cord interneurons, midbrain dopa-
minergic and cortical pyramidal neurons, from rodent and
human embryonic stem cells [11–17]. However, the ethical
and logistical considerations associated with the use of hu-
man blastocytes, from which embryonic stem cells are de-
rived, often makes this approach difficult, especially when
investigating the basic mechanisms underlying neurodeve-
lopment. An alternative approach has been the creation of
conditionally immortalised hNPCs, generated from post-
mortem human fetal tissue [2, 5, 6, 14]. Recently several
clonal, conditionally immortalised hNPC lines were iso-
lated from first trimester human fetal tissues [14]. These
cells were conditionally immortalised using retroviral inte-
gration of a single copy of the c-mycERTAM construct. Thus,
in the presence of 4-hydroxytamoxifen (4-OHT) and de-
fined growth factors, these hNPCs retain their self-renewing
properties. However, upon withdrawal of 4-OHT and
trophic support, and the addition of a medium that pro-
motes neuronal differentiation, these cells terminally differ-
entiate into functional neurons that retain regional identity
[14]. Indeed, immortalised hNPCs isolated from first trimes-
ter human fetal spinal cord, midbrain, hippocampus and
cortex have been successfully differentiated into functional
neurons and interneurons both in vitro and in vivo [12, 14,
18, 19]. These hNPC lines have already been used to investi-
gate the mechanisms of antidepressant drug action [18], to
characterise the biological functions of susceptibility genes
for schizophrenia and bipolar disorder [20] and are currently
in trial for engraftment following ischaemic stroke [21].
However, in order to fully understand how such mecha-
nisms may impact early neurodevelopment, and in particu-
lar corticogenesis, it is critical to determine whether these
cell lines can a) robustly differentiate into glutamatergic
neurons in vitro; b) display functional responses to activation
of neurotransmitter signalling systems; c) form putative
synapses; and d) are able to respond to activity-dependent
stimulations in the anticipated manner.
Here we report that the conditionally immortalised
CTX0E16 hNPCs are capable of generating glutamatergic
neurons under defined culturing conditions. These neu-
rons expressed a range of neuronal proteins and demon-
strated spontaneous and evoked Ca2+ responses and
activation of intracellular signalling cascades in response to
exogenous neurotransmitter application. Critically, differ-
entiated neurons developed electrophysiological properties
typical of young, immature neurons. CTX0E16 neurons
also demonstrated morphological maturation over time,
expressed a range of pre- and post-synaptic proteins, and
displayed structural plasticity in response to modulation of
neuronal activity. Collectively, these data demonstrate that
the CTX0E16 hNPC line is an ideal platform from which
investigations into basic and disease-relevant neurodeve-
lopmental mechanisms can be investigated in native hu-
man neurons.
Materials and methods
Cell culture
Use of the CTX0E16 cell line was kindly granted by
ReNeuron Group plc (Guildford, UK) under a Material
Transfer Agreement. Derivation of this conditionally
immortalised human NPC line has been described previ-
ously [14, 19]. In brief, CTX0E16 cells were obtained from
the developing embryonic cortex of a 12-week gestation
fetus and conditionally immortalised by ectopic expression
of the c-MycERTAM transgene [14]. This construct main-
tains self-renewal of the cells in the presence of 4-OHT.
CTX0E16 hNPCs were cultured in reduced modified
medium (RMM: DMEM:F12 with 15 mM HEPES and
sodium bicarbonate (Sigma, St. Louis, MO, USA) supple-
mented with 0.03 % human serum albumin (GE Healthcare
Life Sciences, Buckinghamshire, UK), 100 μg/ml apo-
transferrin (Scipac Ltd, Kent, UK), 16.2 μg/ml putrescine
(Sigma, St. Louis, MO, USA), 5 μg/ml human insulin
(Sigma, St. Louis, MO), 60 ng/ml progesterone (Sigma, St.
Louis, MO, USA), 2 mM L-glutamine (Sigma, St. Louis,
MO, USA) and 40 ng/ml sodium selenite (Sigma, St. Louis,
MO, USA)). To maintain proliferation 10 ng/ml human
fibroblast growth factor (FGF)2 (PeproTech, Rocky Hill,
NJ), 20 ng/ml human epidermal growth factor (EGF)
(PeproTech, Rocky Hill, NJ) and 100 nM 4-OHT (Sigma,
St. Louis, MO, USA were also added to RMM. CTX0E16
hNPCs were seeded onto Poly-D-lysine (PDL, 5 μg/cm2;
Sigma, St. Louis, MO, USA) and laminin-coated (1 μg/cm2;
Sigma, St. Louis, MO, USA) tissue culture flasks, with full
media changes occurring every 2–3 days. Cells were pas-
saged once they reached 70–80 % confluence using Accu-
tase (Sigma, St. Louis, MO, USA) and maintained for
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between 25 and 30 passages; all experiments were carried
out using cells from passages 12 to 30.
Neural progenitor cell differentiation
CTX0E16 cultures were maintained under proliferative
conditions until 70–90 % confluent, then washed twice
with non-supplemented DMEM:F12 medium and passaged
onto PDL (5 μg/cm2) and laminin-coated (1 μg/cm2) tissue
culture flasks or No. 1.5 coverglass (Paul Marienfeld
GmbH & Co. KG, Lauda-Königshofen, Germany) at a
density of 50,000 cells per ml. Cells were then washed in
warm Dulbecco’s phosphate-buffered saline (DPBS; Life
Technologies, Paisley, UK) and maintained in neuronal
differentiation media (NDM: Neurobasal Medium (Life
Technologies, Paisley, UK) supplemented with 0.03 %
human serum albumin (GE Healthcare Life Sciences,
Buckinghamshire, UK), 100 μg/ml apo-transferrin (Scipac
Ltd, Kent, UK), 16.2 μg/ml putrescine (Sigma, St. Louis,
MO, USA), 5 μg/ml human insulin (Sigma, St. Louis, MO,
USA), 60 ng/ml progesterone (Sigma, St. Louis, MO,
USA), 2 mM L-glutamine (Sigma, St. Louis, MO, USA),
40 ng/ml sodium selenite (Sigma, St. Louis, MO, USA)
and 1 × B27 serum-free supplement (Life Technologies,
Paisley, UK). Half medium changes were performed every
2–3 days and cultures were differentiated for up to 61
days (days differentiated (DD) 61).
Transfection
Differentiated CTX0E16 neurons were transfected at the
desired age using Lipofectamine 2000 (Life Technolo-
gies, Paisley, UK) as previously described [22]. Briefly, 2
μg of peGFP-C1 was mixed with 2 μl of Lipofectamine
2000 and incubated for 20 minutes in a humidified at-
mosphere of 95 % air/5 % CO2 at 37 °C with open caps.
The DNA:Lipofectaimine 2000 mixture was added drop-
wise to CTX0E16 neurons, and cells were incubated for
4 hours at 37 °C, before being transferred to new wells
containing fresh media. Transfections were allowed to
proceed for 2 days before either treatment or fixation
and subsequent immunocytochemical analysis.
Immunocytochemical analysis and microscopy
Prior to fixing, CTX0E16 cells were washed once in warm
PBS. Cells were then fixed in either 4 % formaldehyde/4 %
sucrose in PBS at room temperature for 20 minutes, or in
4 % formaldehyde/4 % sucrose in PBS at room temperature
for 10 minutes followed by two washes with PBS and incu-
bation with pre-chilled (−20 °C) methanol for 10 minutes
at 4 °C. Methanol fixation was used to unmask protein in
lipid rich structures, such as the post-synaptic density [22].
Cells were washed a further two times in PBS and then
blocked in PBS containing 30 % normal goat serum with
0.1% Triton X-100 (Sigma, St. Louis, MO, USA) for 2
hours at room temperature. Primary antibodies were added
in PBS containing 10 % normal goat serum overnight at
4 °C, followed by 3 × 15-minute washes in PBS. Cells were
then incubated for a further hour in 10 % NGS with 0.1 %
Trinton X-100, before incubation with Alexa, 488, 568 or
633 secondary antibody (Life Technologies, Paisley, UK)
diluted in PBS with 10 % normal goat serum for one hour
at room temperature. Two further washes (15 minutes
each) were performed before coverslips were washed once
with PBS containing 0.1 % 4′,6-diamidino-2-phenylindole
(DAPI), and then mounted using ProLong antifade reagent
(Life Technologies, Paisley, UK). A list of antibodies used
in this study can be found in Additional file 1: Table S1.
For some conditions, representative images were taken on
a Zeiss Axio Imager Z1, equipped with an ApoTome and an
AxioCam MR3 camera running AxioVision 4.7.1 imaging
software (Carl Zeiss, Jena, Germany). Images of double- and
triple-labelled neurons were obtained using a Lecia SP5
confocal microscope and × 63 objective (N.A. 1.4). Images
were taken as a z-series (z-step = 0.4 μm). All images were
exported to ImageJ [23] where maximum intensity projec-
tions and background subtracted images were generated
[22]. In the green/purple colour scheme, co-localization is
indicated by white. Images were taken in the linear range, to
allow an accurate representation. Each channel is shown in-
dividually in greyscale.
Cell counts were performed using images acquired with
either a Zeiss Axioimager or Olympus IX70 with × 20
objective (N.A. 0.8), with at least four fields of view (FOV)
imaged per biological replicate per condition. Three bio-
logical replicates were imaged for each staining condition at
each of the time points assessed, with one to two technical
replicates for each. Z-stacks of four slices at 1 μm between
each slice were Z-projected and the resulting projections
were background subtracted. In all conditions, the DAPI
channel was thresholded and regions of interest (ROI) were
created around each nucleus and used to assess expression
of MAP2 along with the various markers of cell identity via
the average intensity of each area in the respective channels.
The percentage of cells expressing each marker in each bio-
logical replicate was calculated relative to the total number
of cells (DAPI-positive cells) and the number of MAP2-
positive cells. These percentages for each biological repli-
cate were then averaged and the standard errors calculated.
All image processing for the quantification of cell counts
was performed using ImageJ, and all subsequent analysis of
these data was performed using Microsoft Excel.
RNA preparation, cDNA synthesis, reverse transcription
PCR (RT-PCR) and quantitative PCR (q-PCR)
Proliferative and differentiated (28 days) CTX0E16 cells were
pelleted and lysed using TRIzol reagent (Life Technologies,
Paisley, UK) and total RNA extracted according to the
manufacturer’s instructions. Residual genomic DNA was
removed from each of four biological replicates using the
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TURBO DNA-free™ Kit (Life Technologies, Paisley, UK)
according to published protocols. cDNA was synthesized
from 1.5 μg of total RNA from each extraction using ran-
dom decamers and SuperScript III (Life Technologies,
Paisley, UK), according to the manufacturer’s instructions.
To determine the expression of specific genes, primers
were designed to target all known RefSeq transcripts of
genes of interest, sourced from the University of California
Santa Cruz (UCSC) Genome Browser website [24]
(Additional file 1: Table S2). Where possible, primers were
designed to span intronic regions of the selected genes to
ensure specific amplification of mRNA, even in the pres-
ence of DNA contamination. Reactions were carried out
in a total volume of 20 μl containing diluted cDNA, 1 ×
HOT FIREPol Blend Master Mix (Solis Biodyne, Tartu,
Estonia) and primers at 200 nM, using a GS4 thermal
cycler. Samples were separated and visualised by poly-
acrylamide gel electrophoresis.
For quantitative expression analysis, 20 μl cDNA samples
from SuperScript III reactions were diluted with a further
120 μl of nuclease-free H2O. Reactions were carried out in a
total volume of 20 μl, containing diluted cDNA, 1 × HOT
FIREPol® EvaGreen® q-PCR Mix (Solis Biodyne, Tartu,
Estonia) and primers at 200 nM, using an MJ Research
Chromo 4 (Bio-Rad, Hercules, CA, USA) and MJ Opticon
Monitor analytic software (Bio-Rad, Hercules, CA, USA).
Triplicate q-PCR reactions were performed to measure each
gene in each cDNA sample. The level of each gene was
measured against a standard curve constructed by serial di-
lution of pooled cDNA from all assayed samples. A relative
value was thus obtained for each of the three triplicate reac-
tions for each cDNA sample. Mean measures of target genes
were then normalized against a geometric mean determined
from three internal control genes (GAPDH, HPRT1 and
RPL13A) for each cDNA sample to yield a relative target
gene expression value for all samples. GAPDH, HPRT1 and
RPL13A were identified as suitable internal controls on the
basis of previous whole-genome microarray data of
CTX0E16 cells, where it showed the least variability (in
terms of standard deviation) across conditions. Normalized
q-PCR target gene expression values were compared be-
tween proliferative (DD 0) or DD 28 CTX0E16 cells.
Calcium imaging
For experiments to assess responsiveness of CTX0E16 cells
to exogenous neurotransmitter ligands, cells were differen-
tiated for 28 days (DD 28) on PDL (5 μg/ml) and laminin-
coated (1 μg/cm2) glass coverslips, and then incubated with
HEPES-buffered physiological saline solution (140 mM
NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM
HEPES and 10 mM glucose, buffered to pH 7.4 using 5 M
NaOH) supplemented with 2.5 μM Fura-2 AM and 1 mM
probenecid (loading buffer) at 37 °C for 60 minutes before
being replaced with assay buffer (loading buffer minus
Fura-2 AM and probenecid). Images of a group of cells
were taken every 2 seconds with × 10 objective at the 520
nm emission wavelength following excitation at 340 and
380 nm using a microscope-based imaging system (Photon
Technology International, Birmingham, NJ, USA). Each ex-
periment began with 2 minutes of baseline readings to
allow cells to settle before the addition of the neurotrans-
mitter compound being tested (dopamine, glutamate or
acetylcholine; Sigma, St. Louis, MO, USA) at 1 mM, di-
luted in HEPES-buffered physiological saline solution, to
which cells were exposed for one minute. Image analysis
of individual cells by emission intensity ratios from 340
nm/380 nm excitation were performed, using the
ImageMaster software (Photon Technology International,
Birmingham, NJ, USA).
To investigate spontaneous Ca2+ transients in CTX0E16
neurons, cells were differentiated for 42 days on coverslips,
then loaded with 2 μM Fluo-4-AM dye (Life Technologies,
Paisley, UK) in HEPES-buffered physiological saline solu-
tion (140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, 10 mM glucose and buffered to
pH 7.4 using 5 M NaOH) supplemented with 0.02 %
Pluronic-F27 (Life Technologies, Paisley, UK) for 15
minutes at 37 °C, followed by washing in HEPES-buffered
physiological saline solution for a further 15 minutes at 37
°C. Fluo-4 fluorescence was time-lapse-recorded (1 second
intervals) with MetaMorph (Molecular Devices, Sunnyvale,
CA, USA) on an Axiovert S100 microscope (Carl Zeiss,
Jena, Germany) equipped with appropriate filter sets
(Chroma Technology, Bellows Falls, VT, USA), a × 40
(N.A. 1.3) PlanNeofluar objective (Carl Zeiss, Jena,
Germany) and a Photometrics Cascade-II 512B EMCCD.
Indicated agonists, KCl (50 mM) and Tetrodotoxin (TTX;
1 μM), were diluted in HEPES-buffer and added to cells to
give the final concentration. In all experiments, 10 μM
ionomycin was added as a second stimulation for the dye
loading control. Offline analysis of the intensity pattern of
the Fluo-4 signal was performed in ImageJ. ROI were
drawn around the soma of cells with clear dendritic pro-
cesses. Spontaneous activity was categorized when at least
one clear neuronal calcium event was detected on a soma.
Neuronal calcium events were defined as a sharp transient
increase in fluorescence intensity: Fluo-4, ΔF/F0 >5%, with
a fast rise and slower decay.
Electrophysiology
Electrophysiological recordings were obtained from
CTXOE16 neurons differentiated for between 29 and 61
days. Patch pipettes (4.0–7.5 MΩ) were pulled from boro-
silicate glass capillary tubes using a P97 Flaming/Brown
Micropipette Puller (Sutter Instruments). The internal
patch solution contained (in mM) 135 KGluconate, 10
KCl, 1 MgCl2, 10 HEPES, 2 Na2-ATP and 0.4 Na3-GTP.
All recordings were conducted at room temperature. The
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external recording solution contained (in mM) 139 NaCl,
2.5 KCl, 10 HEPES, 10 Glucose, 2 CaCl2 and 1.3 MgCl2.
For recordings in older cells (DD 55−DD 61) electro-
physiological recordings were conducted in NDM. Whole
cell voltage clamp recordings were conducted at a holding
potential of −70 mV to monitor predominantly α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor-mediated spontaneous excitatory post synaptic
currents (EPSCs) and at +40 mV to monitor EPSCs medi-
ated by N-methyl-D-aspartate (NMDA) receptors. A
stable access resistance was maintained between 20–35
MΩ for the duration of these recordings with no series
resistance compensation. In some cases, tight-seal cell-
attached recordings were conducted in order to monitor
spontaneous action potential firing. In all experiments,
corrections were made for liquid junction potentials off-
line. Data were generated and acquired using an EPC10
amplifier (Heka Instruments, Bellmore, NY, USA) and the
software PatchMaster. Data were sampled at 15 kHz and
filtered at 3 kHz.
ERK1/2 phosphorylayion assay
The ability of neurotransmitter compounds (dopamine,
glutamate or acetylcholine; Sigma) to activate Extracellular
signal-regulated kinases 1, 2 (ERK1/2) in differentiated (DD
28) CTX0E16 neurons, was assessed using the Cellul’erk
Kit (Cisbio Bioassays, Codolet, France). Cells were plated
onto laminin-coated (0.5 μg per well) clear 96-well plates at
a density of 30,000 cells per well. Cells were incubated with
the neurotransmitter compounds to be tested for 0–60
minutes. Neurons were then lysed in lysis buffer supple-
mented with blocking reagent and incubated for 5
minutes at room temperature with shaking. Cell lysates
from each well were then transferred to wells of a 384-
well, solid bottom, small volume, white plate (Greiner,
Stonehouse, UK) and mixed with 2 μl of each of the two
HTRF conjugates (anti-ERK1/2-Eu3+-cryptate (donor) and
anti-phospho-ERK1/2-d2 (acceptor)) before being incu-
bated for 2 hours at room temperature. Each 384-well plate
additionally contained 6 wells dedicated to negative (16 μl
of blocking reagent-supplemented lysis buffer with 2 μl of
anti-ERK1/2-Eu3+-cryptate donor conjugate and 2 μl of de-
tection buffer - donor antibody only) and blank (16 μl of
blocking reagent-supplemented lysis buffer with 2 μl of
each of the donor and acceptor conjugates) controls,
respectively. Plates were then read using a FlexStation 3 or
Artemis K-101 plate-reader. Readings were made at 620
nm for the donor (Eu3+-cryptate) and 665 nm for the
acceptor (d2) following excitation at 314 nm. Readings were
an average of 50 replicates with a delay and integration time
of 100 μ seconds. A 665 nm/620 nm ratio was calculated
for each well/assay and referred to as R. A mean R value
was calculated for the 6 negative control wells on each 384-
well plate and referred to as RNeg. Values were expressed as
ΔF% according to the following equation as defined by
Albizu and colleagues [25]:
ΔF% ¼ R − RNeg
RNeg
 100
ΔF% values were analysed using GraphPad Prism.
Neuronal treatment: chronic neuronal depolarisation
DD 13 CTX0E16 neurons were transfected with en-
hanced green fluorescent protein (eGFP) as described
previously. At DD 15, media were replaced with warm
experimental media for each of the three experimental
conditions: NDM supplemented with pure water, NDM
supplemented with 30 mM NaCl as an osmotic control
or NDM supplemented with 30 mM KCl. Cultures were
fixed and immunostained after 7 hours of exposure to
the experimental media. Cells were imaged using a Zeiss
fluorescence microscope with × 63 objective (N.A. 1.4).
Only cells with a neuronal morphology and more than
one neurite were imaged for the purpose of assessing
neurite length. Images were processed using ImageJ and
neurites were traced using the NeuronJ plugin. Imaging
and neurite tracing was carried out with the experi-
menter blinded to experimental condition.
Statistics
For all experiments, two to four technical replicates
from three to four independent cultures/passages were
used. For all graphs, bars represent means and error bars
as either SD (Figs. 1 and 2) or standard error of the
mean (SEM). To identify differences among conditional
means, statistical analyses (Student’s unpaired t test, ana-
lysis of variance (ANOVA)) were performed in either
Excel or GraphPad Prism 5. Tukey post hoc analysis was
used for multiple comparisons.
Results and discussion
CTX0E16 cells differentiate into neurons of distinct
lineages
A number of immortalised hNPC lines generated from
human fetal ventral telencephalon, spinal cord or cortex
have previously been described. These lines were condi-
tionally immortalised using either a c-myc or v-myc
transgene, and have been shown to differentiate into
specific neural cell types under specified neural growth
mediums [6, 11–16]. Therefore, we initially sought to
determine whether differentiated CTX0E16 NPCs were
capable of adopting a neuronal fate. Proliferative (DD 0),
CTX0E16 NPCs were routinely maintained as a mono-
layer in RMM for up to 30 passages. As expected these
cells expressed the intermediate filament protein nestin
and Sox2 neural precursor markers, indicative of an
NPC phenotype (Fig. 1a, b). Proliferative CTX0E16 cells
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also highly expressed KI67, a marker of cell proliferation;
however, the number of KI67-positive cells was signifi-
cantly reduced 5 days after cells were cultured in NDM
(percent total cells positive for KI67: DD0, 91.4 ± 3.69;
DD5, 52.8 ± 2.31; p <0.001, Fig. 1c-e). This indicated
that proliferation of CTX0E16 cells was rapidly halted
following initiation of differentiation.
We next examined the neural cell type into which
CTX0E16 cells differentiated. Under proliferative condi-
tions less than 10 % of cells were positive for the astro-
cyte and ependymal cell marker, S100β, or the neuronal
markers Tau or MAP2 (Fig. 1f-l). Conversely, after 28
days of differentiation (DD 28) there was a marked in-
crease in the number of Tau and MAP2 positive neu-
rons; no change in S100β-positive cells was observed
(Fig. 1f-l). These data indicate that differentiation of
CTX0E16 NPCs resulted in the generation of cells with
a neuronal fate.
Previously characterised hNPCs have been shown to
retain an identity associated with the region from which
they were derived [5, 11, 12, 14–16]. In addition, studies
using mouse or human embryonic stem cells, or human
Fig. 1 Characterisation of undifferentiated and differentiated CTX0E16 hNPCs. a, b Representative images of undifferentiated (days differentiated
(DD) 0) CTX0E16 cells immunostained for the neural progenitor cell (NPC) markers nestin (a) and Sox2 (b). c At DD 0, the majority of CTX0E16
NPCs were positive for the cell proliferation marker, KI67. d By DD 5, the number of KI67-positive CTX0E16 cells had greatly reduced. e Quantification
of the number of KI67 positive cells as a percentage of total cells; n = approximately 1,500 cells from three independent experiments carried out in
triplicate; error bars represent SD; ***p <0.001 (Student’s unpaired t test). f, g Only a few cells were positive for the astrocyte marker S100β at DD 0 (f)
or DD 28 (g). h, i At DD 0 very few cells expressed the neuronal marker Tau (h). However, after 28 days of differentiation, the majority of cells expressed
Tau (i). j, k Similarly, very few cells were positive for the neuronal marker MAP2 at DD 0 (j), but by DD 28 the majority of cells were positive for MAP2,
indicating that the vast majority of cells at this time point had differentiated into neurons. l Number of proliferative (DD 0) or differentiated (DD 28)
cells positive for S100β, Tau or MAP2; N = approximately 1,500 cells from three independent experiments carried out in triplicate; error bars represent
SD; ***p <0.001 (two way analysis of variance with Tukey post hoc analysis). m Quantitative PCR (q-PCR) analysis revealed an increase in the expression
of dorsal forebrain marker, EMX1 and cortical neuron marker TBR1 in DD 28 CTX0E16 neurons compared to DD 0 cells; n = 4 independent experiments
carried out in triplicate; error bars represent SD; ***p <0.001 (Student’s unpaired t test). Scale bar, 50 μm. DAPI 4′,6-diamidino-2-phenylindole
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induced pluripotent stem cells (hiPSCs), have shown that
withdrawal of mitogens and culturing in the presence of
factors associated with generation of telencephalon/
forebrain cells, results in the production of glutamater-
gic projection neurons of all cortical layers [17, 26, 27].
Thus, we reasoned that differentiated CTX0E16 neu-
rons would express markers of cortical identity. Consist-
ent with this, q-PCR analysis revealed a significant
increase in the dorsal forebrain marker EMX1, and the
cortical marker TBR1 28 days after differentiation, indi-
cating that CTX0E16 NPCs were differentiating into
neurons with a cortical identity (Fig. 1m). In vivo, a fun-
damental characteristic of cortical stem cells is the gen-
eration of neurons into layer-specific neuronal subtypes,
as determined by the expression of a number of specific
molecular markers [17, 26, 27]. Therefore, to examine
whether differentiated CTX0E16 cells generated a
diverse population of cortical neurons, we assessed
whether they expressed specific cortical layer markers.
Accordingly, we found that 41.6 % of MAP2 neurons
were positive for Ctip2 (Fig. 2a, e), a marker of deep-
layer cortical neurons, consistent with the observed in-
crease in TBR1 expression. Conversely, less than 10 %
of MAP2 neurons were positive for the upper layer
marker Cux1 (Fig. 2b, e). Next we examined whether
any subtypes of GABAergic interneurons were present
in our cultures. Interestingly, less than 10 % of MAP2
neurons were calretinin-positive or calbindin-positive
Fig. 2 Differentiation of CTX0E16 cells generates glutamatergic cortical neurons. a-d Representative images of differentiated (DD 28) CTX0E16
neurons co-stained for 4′,6-diamidino-2-phenylindole (DAPI), MAP2 and either the deep cortical layer marker Ctip2 (a), the upper cortical layer marker
Cux1 (b), GABAergic interneuron marker calretinin (c) or calbindin (d). Yellow arrows indicate neurons expressing these markers. e Quantification
revealed that 41.6 % of MAP2-positive neurons expressed Ctip2, whereas less than 10 % of MAP2-labelled neurons were positive for Cux1, calretinin or
calbindin; n = approximately 1,500 cells per condition from three independent experiments carried out in triplicate; error bars represent SD.
(f, g) Images of DD28 CTX0E16 neurons co-stained for DAPI, MAP2 and the glutamatergic and excitatory markers VGlut1 (f) or CaMKIIα (g). h, i
DD 28 CTX0E16 neurons were also co-stained for DAPI, MAP2 and the GABAergic markers GAD65/67 (h) or VGAT (i). j Quantification of F-I
revealed that over 65 % of MAP2-psoitive neurons also expressed VGlut1 or CaMKIIα, whereas less than 45 % of MAP2-neurons were also
positive for either GAD65/67 or VGAT; n = approximately 1,500 cells per condition from three independent experiments carried out in triplicate;
error bars represent SD. Scale bar, 20 μm
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cells (Fig. 2c-e); no parvalbumin-positive cells were de-
tected. One possible explanation for the lack of parval-
bumin interneurons in our cultures is that this subtype
of GABAergic interneurons is only observed at a later point
during the development of the neocortex [11, 28, 29].
Nevertheless, these data indicate that the majority of
neurons generated by CTX0E16 NPCs are pyramidal
neurons. Consistent with this observation, 67.1 ± 10.15
% of MAP2 neurons expressed the glutamatergic and
pyramidal marker Vesicular glutamate transporter 1
(VGlut1, also known as SLC17A7) and 75.2 ± 8.74 % of
MAP2 neurons were positive for excitatory neuronal
marker CaMKIIα (Fig. 2f-g, j). Both VGlut1 and CaMKII
were detected in the cell soma, and along processes in
puncta structures, suggesting that at least some of these
proteins may be present at synapses. Interestingly,
VGlut2 has been found to be present in the cytoplasm
of immature mouse neurons and in immature neurons
derived from mouse ESCs [30, 31]. It has been sug-
gested that during early development, and in particular
during axogenesis or synaptogenesis, neurons produce
high levels of synaptic proteins, such as VGlut2. There-
fore, the presence of VGlut2, may result from an accu-
mulation of protein in the cell body waiting to be
transported out along axons [31]. Thus, it is also pos-
sible that the presence of VGlut1 in the cell soma of DD
28 CTX0E16 may be indicative of accumulated protein
waiting to be transported out along axons to newly
formed synapses. Remarkably, a significant number of
CTX0E16 neurons also expressed the GABAergic marker
GAD65/67 (39.3 ± 11.5 %) (Fig. 2h, j) suggesting that
CTX0E16 may be forming inhibitory synapses. In agree-
ment with this, a subpopulation of CTX0E16 neurons
(44.6 ± 11.1 %) also displayed punctate staining for the
vesicular GABA transporter (VGAT). Indeed, VGAT im-
munoreactivity was found mainly around the cell soma
(Fig. 2h-j), indicating that these cells were potentially re-
ceiving GABAergic inputs. The relatively high expression
of inhibitory markers in contrast to the low number of in-
terneurons could be explained by the fact that GABAergic
synapses are functionally excitatory during development
[32]. Critically, these data suggest that, of the neurons
generated, the majority of cells display characteristics of
glutamatergic projection (cortical) neurons, with only a
few GABAergic interneurons being generated.
Collectively, these data indicate that CTX0E16 cells
are multipotent and can differentiate into distinct neural
sub-types. While this includes a small number of astro-
cytes and GABAergic interneurons, the majority of neu-
rons generated express a subset of molecular makers
consistent with the formation of glutamatergic cortical
neurons of distinct cortical layers. Thus, our data sug-
gest that as NPCs generate neurons of a fate synonym-
ous with their region of origin.
Differentiated CTX0E16 neurons exhibit typical pyram-
idal neuronal morphology. An important characteristic of
cortical glutamatergic neurons is their ability to generate
unipolar pyramidal neuronal morphology: interneurons
display multipolar morphologies [17, 33, 34]. In vivo
this is typified by the generation of unipolar neurons
with a single apical dendrite that projects to the pial
surface [35–37]. In vitro, primary rodent neuronal cul-
tures have also been shown to generate unipolar neu-
rons, with a distinct primary dendrite (akin to apical
dendrites in vivo) [33, 36–38]. Moreover, the generation
of this polarized morphology in vitro can be divided into
several distinct stages: 1) generation of small neurite
processes; 2) specification of a single axonal process; 3)
formation of dendrites from remaining neurites; 4) mat-
uration of axonal and dendritic processes and formation
of synaptic connections [33]. To investigate the devel-
opment of neuronal morphologies in differentiated
CTX0E16 neurons, cells were fixed at early stages of dif-
ferentiation (DD 0, DD 2 and DD 4) and immuno-
stained for βIII Tubulin (Tuj1), a marker of young
neurons (Fig. 3a-c). After two days of differentiation,
CTX0E16 cells had begun to extend neurite-like pro-
cesses (Fig. 3b, arrow heads), while by day 4 of differen-
tiation the amoeboid morphology of the NPCs was
found to have developed into a more neuronal-like ap-
pearance, with cells exhibiting multiple neurites (Fig. 3c,
arrow heads). In order to examine the morphology of
neurons differentiated for longer periods of time, we
transfected cells with eGFP to outline cell morphology.
By DD 15, CTX0E16 neurons had adopted a polarised
neuronal morphology; the extension and arborisation of
a single process, characteristic of the specification of an
axonal process, could be clearly identified (Fig. 3d).
After 20 days of differentiation, maturation of the axon
had occurred, and the formation of a primary dendrite
was evident (Fig. 3e). By DD 35, CTX0E16 neurons had
formed dendrites with secondary and tertiary dendritic
arborisations, indicative of a young, yet maturing pyr-
amidal neuron (Fig. 3f ). Numerous studies have demon-
strated that cultured rodent cortical neurons develop a
typical polarised morphology with primary and non-
primary dendrites: primary dendrites resemble apical
dendrites in vivo, while non-primary dendrites resemble
basal dendrites, as seen in vivo [36, 37, 39]. We find that
after 35 days of differentiation, a single long dendrite,
with several branches, can be observed. This is likely to
be the primary dendrite. Very few non-primary den-
drites were seen at DD 35, however, this is likely due to
the fact that in vivo, basal dendrites are formed after the
initial establishment of the apical dendrites [35], a
phenomenon that is recapitulated in vitro [36].
Another hallmark of the generation of morphologically
accurate cortical neurons in vivo is that the trans-Golgi
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network can also be seen in the apical dendrite [36, 38–40].
Interestingly, in primary neuronal cultures, the trans-
Golgi network has been shown to extend into the pri-
mary dendrite, consistent with the formation of a
polarised morphology [36, 38–40]. Thus, to further con-
firm whether CTX0E16 neurons generated polarised
neuronal morphologies, we stained DD35 cultures for
the dendritic marker MAP2 and the cis-Golgi network
protein, GM130. The majority of MAP2-positive neu-
rons had discernible GM130 staining within the soma
(Fig. 3g). Interestingly, high magnification close-ups
demonstrated that in the majority of MAP2-positive
CTX0E16 neurons, GM130 was orientated towards a sin-
gle MAP2-process, typically the longest process, indicative
of the formation of a polarised neuronal morphology
(Fig. 3h). Moreover, GM130 was occasionally seen to ex-
tend into a single dendrite, consistent with the formation
of a primary dendrite, but also of a secretory network indi-
cative of a functional neuron (Fig. 3h). Critically, these
findings further indicate that differentiated CTX0E16 cells
develop neurons with a morphology and polarisation con-
sistent with that associated with glutamatergic pyramidal
neurons.
Expression of neurotransmitter receptor, signalling
proteins and disease-related proteins
The ability of CTX0E16 NPCs to differentiate into
neurons with a mainly glutamatergic phenotype led us
to question whether these cells also express a range
of neuronal genes (Additional file 1: Table S2). Using
Fig. 3 Differentiated CTX0E16 neurons display morphological features of pyramidal neurons. a-c Generation of small neurites in βIII Tubulin
(Tuj1)-positive CTX0E16 cells after 2 or 4 days of differentiation. d-f Expression of green fluorescent protein (GFP) in young CTX0E16 neurons,
reveals the development of neuronal morphology; at differentiation day (DD) 15, neurite processes extend from the cell’s soma (d). By DD 20, a
single long and thin process can be seen emerging from the cell’s soma with a thicker single process also emerging from the opposite side.
Note the pyramidal shape of the cell soma. f By DD 35, the dendritic process displays some level of arborisation; additional smaller processes
protruding from the cell soma are also evident. g, h Double immunostaining of DD 35 CTX0E16 neurons for the trans-Golgi marker, GM130 and
MAP2. In MAP2-positive neurons, GM130 is clearly seen orientated towards a single, typically the longest, dendrite (red arrows). This indicates the
primary dendrite, and the formation of a polarized morphology (g). h High-magnification images reveal that the Golgi-network is present along
the primary dendrites (red arrow). Scale bars, 20 μm (a-g) and 5 μm (h). DAPI 4′,6-diamidino-2-phenylindole
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RT-PCR, proliferative CTX0E16 NPCs were found to
express a select number of neurotransmitter-targeted
G-protein-coupled receptors (GPCRs) and ionotropic
receptor subunits, including those belonging to gluta-
matergic, dopaminergic, serotonergic and cholinergic re-
ceptor families, and calcium channels (Additional file 1:
Figure S1). Expression of signalling hub molecules GSK-
3β (GSK3B), DARPP-32 (PPP1R1B) and SLC6A4, and the
adaptor proteins, ARRB2, CAV1, DLG4 and MPDZ, were
also detected in CTX0E16 NPCs. Following 28 days of dif-
ferentiation, expression at the mRNA level was observed
for all genes evaluated (Additional file 1: Figure S1). Ro-
bust expression was observed for AMPA glutamate recep-
tor subunit GRIA1 and the NMDA glutamate receptor
subunit GRIN1, and for the metabotropic glutamate
receptors, GRM1–GRM8 (Fig. 4a). In addition, DD 28
CTX0E16 neurons also expressed the GPCRs, ADRA1A,
DRD2, DRD3 and HTR2A. Lower expression levels were
seen for CHRM1, HRH1, TACR3 and AVPR1A. The
accessory proteins ARRB2, CAV1, DLG4 and MPDZ and
the 5-HT transporter, SLC6A4, were also found to be
expressed (Additional file 1: Figure S1). We complemen-
ted these studies by analysing the change in expression
level of a subset of key neurotransmitter receptor, synaptic
and signalling protein genes, after 28 days of differenti-
ation. Consistent with our characterisation of neuronal
lineage, DD 28 neurons had significantly higher levels of
the NMDA receptor subunit GRIN1, AMPA receptor sub-
unit, GRIA1, in addition to elevated levels of GABRA1 and
DRD2. The synaptic proteins DLG4 and CAMK2A and
the voltage gated Ca2+ channel CACNA1C were also sig-
nificantly elevated compared to DD 0 CTX0E16 NPCs
(Fig. 4). Collectively, these data suggest that undiffer-
entiated CTX0E16 cells express a range of neurotrans-
mitter receptors and signalling proteins, which are
upregulated during differentiation. Notably, this ex-
pression profile is consistent with differentiation along
a glutamatergic cell fate.
CTX0E16 neurons develop physiological characteristics
Based on our gene profiling and immunostaining data,
CTX0E16 neurons would be expected to express a range
of neurotransmitter receptors, adaptor, scaffold and key
signalling proteins and a number of disease-relevant pro-
teins (Figs. 2 and 4a and Additional file 1: Figure S1).
Thus, in order to determine whether expression of a
range of neurotransmitter receptor genes resulted in
functional integration, we investigated the functional
characteristics of CTX0E16 neurons using calcium im-
aging. At DD 28 CTX0E16 neurons were loaded with
the Fura-2 AM ratiometric dye. Good cell loading of
Fura-2 was demonstrated by CTX0E16 emissions at 520
nm following excitation at 380 nm (Fig. 4b). DD 28
CTX0E16 neurons exposed to 1 mM glutamate (Fig. 4c)
elicited both fast, pronounced responses and slower re-
sponses of a lower magnitude. The fast, pronounced re-
sponses are likely mediated through fast-activated
NMDA or AMPA receptors, while the slower responses
of lower magnitude are attributable to the activation of
metabotropic glutamate receptors [41]. Nearly 80 % of
cells in differentiated CTX0E16 cultures responded to
glutamate, though the responses from these cells were
often modest, with just over 30 % of cells producing a
response of 20 % above baseline and under 20 % produ-
cing responses in excess of 50 % above baseline (Fig. 4g).
The average response from all measured cells was ap-
proximately 20 % above baseline level (Fig. 4h).
Acetylcholine potently and almost ubiquitously caused
increased intracellular Ca2+ concentrations (Fig. 4d),
with more than 60 % of cells producing responses of 20
% above baseline and 40 % producing responses of 50 %
above baseline (Fig. 4g). The average increase in intracel-
lular Ca2+ concentration in response to acetylcholine, al-
most 50 % above baseline, was more than double that
seen in response to glutamate and an order of magni-
tude greater than responses provoked by dopamine
(Fig. 4h). Traces from individual cells exposed to acetyl-
choline showed predominantly rapid and sustained Ca2+
accumulation, though some cells did demonstrate more
gradual increases in Ca2+ levels. In contrast to the rapid
Ca2+ accumulation observed in response to glutamate
and acetylcholine, dopamine provoked much more grad-
ual, and at times delayed, increases (Fig. 4e). This was
expected due to dopamine exerting its actions through
metabotropic receptors alone [42]. In addition to this,
far fewer cells responded to dopamine with increases in
intracellular Ca2+ concentrations. Less than 40 % of cells
produced responses that were more than 5 % above
baseline and less than 3 % produced responses that
achieved levels of 25 % above baseline (Fig. 4g, h).
A hallmark of the generation of neuronal cell types is
the emergence of spontaneous Ca2+ oscillations due to
neuronal activity [43, 44]. No spontaneous Ca2+ oscilla-
tions were observed in DD 28 CTX0E16 cultures. We
therefore differentiated CTX0E16 cells for 6 weeks (DD
42) and performed single cell Ca2+ imaging using Fluo-4
(Fig. 5a). This revealed that 38.0 ± 6.89 % of CTX0E16
neurons displayed spontaneous activity, defined as a sharp
transient Ca2+ flux in a neuronal cell soma (Fig. 5b). In
addition, application of KCl, a depolarising agent, resulted
in a large Ca2+ flux in 79.1 ± 4.2 % of DD 42 CTX0E16
neurons (Fig. 5c), indicating the presence of voltage-gated
Ca2+ channels, consistent with the observed increase in
CACNA1C expression levels upon differentiation (Fig. 4a).
Furthermore, addition of 1 μm tetrodotoxin (TTX)
blocked spontaneous Ca2+ transients (Fig. 5d).
As these data indicated that CTX0E16 neurons were
developing physiological neuronal characteristics, we
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next performed whole cell patch clamp recordings on
CTX0E16 neurons at different stages during development.
This revealed an initially depolarised resting membrane
potential that became progressively more negative with
age (DD 29: −31.3 mV, n = 6; DD 33: −51.25 mV, n = 4;
DD 61: −56.4 mV, n = 3), consistent with increasing neur-
onal maturation occurring over this period (Fig. 5e). Next
we investigated the ability of CTX0E16 neurons to fire ac-
tion potential discharges. Cell-attached voltage clamp re-
cordings were conducted in order to record network
activity without disturbing the intracellular milieu. The
capacity of CTX0E16 neurons to fire single action poten-
tials was only apparent from DD 50 (Fig. 5f). The ability
of these cells to fire repetitively in bursts did not develop
over the time-course of this study. However, it should be
noted that recent studies examining the functional proper-
ties of human induced pluripotent stem cell (iPSC)-de-
rived neurons have demonstrated that co-culturing with
rodent astrocytes or primary neurons induces a faster
maturation of physiological neuronal characteristics [45].
In the current study CTX0E16 were not co-cultured, and
as such, co-culturing these cells with rodent astrocytes or
primary neurons may accelerate the maturation of func-
tional properties in these cells. In addition to investigating
the ability of CTX0E16 neurons to fire action potentials,
whole-cell voltage clamp recordings were conducted to
record spontaneous EPSCs. By DD 33−36 a subset of
CTX0E16 neurons displayed spontaneous EPSCs: pre-
dominantly AMPA receptor-mediated (holding potential
−70 mV) (Fig. 5g) and NMDA receptor-mediated (holding
potential +40 mV) (Fig. 5h) were observed, demonstrating
the presence of functional excitatory synaptic connections.
These findings are consistent with the generation of pre-
dominately excitatory neurons and an increase in the ex-
pression levels of AMPA and NMDA receptor subunits
(Fig. 4a). Recordings were also conducted at 0 mV in
order to isolate GABA-mediated inhibitory postsynaptic
currents. However, no spontaneous postsynaptic currents
were recorded at a holding potential of 0 mV, indicating a
lack of functional inhibitory synapses in these cells. Taken
together, these results indicate that CTX0E16 neurons de-
velop physiological neuronal characteristics that become
progressively more mature with time in culture.
CTX0E16 neurons show increases in ERK1/2
phosphorylation in response to neurotransmitter receptor
activation
In addition to examining changes in Ca2+ levels in re-
sponse to neurotransmitter activation, we further ex-
amined whether activation of these receptors led to the
activation of intracellular signalling cascades. Owing to
the ubiquity of ERK1/2 phosphorylation in response to
neurotransmitter receptor activation and its many
roles in neuronal function [46], this was used as a
means to determine the presence of functional recep-
tors in differentiated CTX0E16 cells. Glutamate,
GABA, dopamine, 5-HT and acetylcholine were shown
to induce ERK1/2 phosphorylation with different tem-
poral profiles (Fig. 6). Glutamate induced a significant
increase in ERK1/2 phosphorylation, peaking after 20
minutes, approximately 85 % above baseline, and grad-
ually returning towards baseline within 60 minutes
(Fig. 6a; p <0.01, ANOVA). GABA induced a more con-
servative, yet significant, phosphorylation of ERK1/2,
again peaking at 20 minutes (approximately 40 % above
baseline) before returning to baseline levels after 50
minutes (Fig. 6b; p <0.05, ANOVA). Application of
dopamine resulted in a delayed increase in ERK1/2
phosphorylation, approximately 80 % after 40 minutes
of exposure, and remaining elevated at 60 minutes
(Fig. 6c, p <0.01, ANOVA). In contrast, a rapid increase
in phosphorylated ERK1/2 levels were detected in re-
sponse to 5-HT within 5 minutes, which reached
approximately 3-fold above baseline levels (Fig. 6d,
p <0.001, ANOVA). This was followed by a very grad-
ual and linear decline that remained nearly 2-fold
above baseline after 60 minutes. Acetylcholine evoked
a modest, but insignificant increase in ERK1/2 phos-
phorylation levels (Fig. 6e). A very gradual increase in
ERK1/2 phosphorylation was seen, resulting in an in-
crease of approximately 30 % in ERK1/2 phosphoryl-
ation 20 minutes after stimulation (Fig. 6e). Taken
together, these data demonstrate that CTX0E16 neu-
rons express a range of neurotransmitter receptors that
are capable of coupling to intracellular signalling cas-
cades, further confirming the functional expression of
various receptor systems.
(See figure on previous page.)
Fig. 4 CTX0E16 cells generate neurons that respond to neurotransmitter stimulation. a Expression of a subset of neurotransmitter receptors,
synaptic and signalling proteins is increased in differentiation day (DD) 28 CTX0E16 neurons as compared to undifferentiated (DD 0) CTX0E16
neural stem cells (NPCs) indexed by quantitative PCR (q-PCR); n = 4 independent experiments carried out in triplicate; error bars represent SD;
**p <0.01; ***p <0.001 (Student’s unpaired t test). b Representative image of neurons loaded with Fura-2 AM used for single cell Ca2+ imaging.
c-e Representative traces of intracellular Ca2+ in response to various neurotransmitter receptor ligands. g Number (%) of total cells generating
5 %, 20 % or 50 % responses following treatment with neurotransmitter ligands; n = 3 independent experiments carried out in triplicate (600 cells
in total). h Mean maximal response produced by DD 28 CTX0E16 neurons following application of neurotransmitter ligands; n = 3 independent
experiments carried out in triplicate (600 cells in total); error bars represent SD
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Fig. 6 Phosphorylation of ERK1/2 kinase in differentiated CTX0E16 neurons following activation of neurotransmitter receptors. a, b Treatment
with glutamate results in a time-dependent increase in phospho-ERK1/2 levels in differentiation day (DD) 28 CTX0E16 neurons. By 60 minutes,
phospho-ERK1/2 levels are still raised as compared to control levels (a). Conversely, GABA application results in a transient increase in phospho-ERK1/2
levels; after 50 minutes, p-ERK1/2 levels have returned to baseline (b). c-e Treatment with dopamine (c) or 5-HT (d) results in activation of ERK1/2;
CTX0E16 neurons respond to dopamine with a slower temporal profile as compared to 5-HT. Phospho-ERK1/2 levels are elevated following application
of acetylcholine, but not significantly compared to baseline; n = 3 independent experiments carried out in triplicate; error bars represent SEM; *p <0.05;
**p <0.01; ***p <0.001 (one way analysis of variance with Tukey post hoc analysis)
(See figure on previous page.)
Fig. 5 Development of functional properties in CTX0E16 neurons. a Representative image of Fluo-4 AM-loaded CTX0E16 neurons used for single
cell Ca2+ imaging. b Representative time series of 18 neurons displaying spontaneous Ca2+ transients. Spontaneous activity was classified as a
somatic calcium event greater than 5 % ΔF/F0: 38.0 ± 6.89 % cells displayed spontaneous activity over an 80-second period of imaging (n = 155
cells from 14 coverslips). c, d Representative traces of intracellular Ca2+ in responses to 50 mM KCl (c) or 1 μM tetrodotoxin (TTX) (d). e Resting
membrane potential (Vm) recorded in current clamp progressively becomes more negative as CTX0E16 neurons become more mature (day of
differentiation (DD) 29−DD 61); error bars represent SD. f Representative action potential recorded in voltage clamp in the cell attached configuration,
recorded from DD 50 CTX0E16 neuron. g Representative voltage clamp recording at a holding potential of −70 mV in DD 36 CTX0E16 neurons.
The downward deflections indicate the presence of AMPA receptor-mediated spontaneous excitatory postsynaptic currents (EPSCs). h Example
of a spontaneous N-methyl-D-aspartate (NMDA) receptor-mediated EPSC recorded in voltage clamp at +40 mV from a DD 33 CTX0E16 neuron;
n = 3–6 cells from at least three independent coverslips
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Expression of synaptic proteins in differentiated
CTX0E16 cells
Glutamatergic (excitatory) synapses comprise the ma-
jority of connections between pyramidal neurons in the
mammalian forebrain. A defining characteristic of these
synapses is the formation of specialised pre- and post-
synaptic structures which contain a wide range of pro-
teins [47]. This includes the presence of scaffold and
glutamate receptor proteins on the post-synaptic side,
as well as proteins associated with synaptic vesicle re-
lease or the uptake/metabolism of neurotransmitters on
the pre-synaptic side. Previous investigations using cor-
tically derived hNPC lines have only superficially dem-
onstrated the presence of synaptic proteins or not at all
[11, 14, 16]. As differentiation of CTX0E16 NPCs
resulted in the generation of cells with a morphology
associated with excitatory cortical neurons (Figs. 2
and 3), and that display electrophysiological proper-
ties characteristic of synaptic connections (Fig. 5),
we investigated whether these cells also expressed
pre- and post-synaptic proteins. By DD 35, immuno-
reactive puncta for the post-synaptic scaffold protein,
postsynaptic density protein 95 (PSD-95, also known
as SAP-90), could be seen along distal MAP2-postive
dendrites in the majority of neurons (Fig. 7a). Con-
sistent with being glutamatergic neurons, these cells
exhibited punctate staining for the AMPA glutamate
receptor subunits, GluA1 and GluA2 (Fig. 7b, c), as well
as for the NMDA glutamate receptor subunit GluN1,
along dendrites (Fig. 7d). Interestingly, gephyrin, a scaffold
protein typically located at inhibitory synapses, was also
observed in puncta structures along MAP2-positive den-
drites, indicating the potential for the presence of inhibi-
tory synapses (Fig. 7e).
We next investigated the presence of a range of pre-
synaptic proteins. Punctate staining for the active zone
marker bassoon and the synaptic vesicle protein synap-
sin 1 could be seen juxtaposed to MAP2-positive den-
drites in DD 35 CTX0E16 neurons (Fig. 7f, g). The
presence of these proteins indicates that the pre-synaptic
machinery required for neurotransmitter release is
present in differentiated CTX0E16 neurons. Further-
more, the glutamate transporter and excitatory synapse
marker VGlut1 was also abundantly present along and
next to MAP2-positive dendrites (Fig. 7h), consistent
with the presence of excitatory synapses and post-
synaptic glutamate receptors. Interestingly, the inhibitory
pre-synaptic proteins VGAT (vesicular GABA trans-
porter) and GAD65/67 were also present as punctate
structures adjacent to dendrites (Fig. 7l, j) albeit at a low
level. Taken together, these data demonstrate that differ-
entiated CTX0E16 neurons express pre- and post-
synaptic proteins indicative of the presence of both exci-
tatory and inhibitory synapses.
Pre- and post-synaptic proteins co-localise along
dendrites in CTX0E16 neurons
Synaptogenesis requires the coordination of a number of
events, including the trafficking of pre- and post-
synaptic proteins to specific locations where synapse
formation can occur [48, 49]. Therefore, we sought to
determine whether these puncta co-localised, thus indi-
cating that CTX0E16 neurons were forming synaptic
connections. In DD 35 CTX0E16 neurons a subset of
PSD-95 puncta co-localised with the pre-synaptic and
active zone marker, bassoon, along distal MAP2-positive
dendrites (red arrows; Fig. 8a). However, not all bassoon
and PSD-95 puncta co-localised with each other (white
open arrowheads; Fig. 8a). This is likely due to the fact
that synaptogenesis is an ongoing event during early
stages of development, and the recruitment of both pre-
and post-synaptic proteins to specific sites is required
[48]. In a similar manner, PSD-95 and synapsin 1 also
displayed partial co-localisation, with several puncta for
each protein unopposed (Fig. 8b). While PSD-95 is pre-
dominately localised to excitatory synapses, it is also
present at inhibitory synapses [47, 50]. Furthermore, re-
cent evidence suggests that VGlut1 and VGAT may co-
exist at synapses, thus allowing for the release of both
glutamate and GABA from select terminals [51]. Inter-
estingly, we detected a small number of PSD-95 puncta
that co-localised with VGAT in DD35 CTX0E16 neurons
(Fig. 8c). This may suggest the presence of synaptic con-
nections, although whether these are excitatory or in-
hibitory connections remains unclear as GABAergic
synapses are thought to be functionally excitatory during
development [32]. Moreover, the detection of overlap-
ping synaptic proteins does not always indicate synaptic
functionality.
During early postnatal development, synaptic dendritic
protrusions first appear as long, thin, highly motile
structures known as filopodia, which can initiate synap-
tic contacts with nearby axons [49, 52]. This initial con-
tact between pre- and post-synaptic sides is a key step in
synaptogenesis. The subsequent maturation and stabil-
isation of synapses is thought to involve filopodia trans-
forming into highly specialised dendritic protrusions
known as dendritic spines [49, 52]. In the mammalian
forebrain, dendritic spines are the site where the
majority of excitatory synaptic connections are located,
and house the post-synaptic component of synapses
[22, 47, 49, 52]. Based on our immunostaining data, we
speculated that differentiated CTX0E16 neurons might
display these dendritic protrusions. Detailed examin-
ation of distal dendrites of DD 35 CTX0E16 neurons
expressing eGFP, as a morphological marker, revealed
the presence of long, thin dendritic protrusions, with
morphology consistent with that of filopodia (Fig. 8d).
In a subset of neurons, smaller dendritic protrusions,
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occasionally defined by the presence of neck and head
structures, were observed (Fig. 8e); such morphology is
consistent with dendritic spines and maturation of syn-
aptic connections. In support of this, western blotting
of differentiated CTX0E16 neurons demonstrated an
increase in expression of PSD-95 over time (Fig. 8f ).
Collectively, the pattern of juxtaposed pre- and post-
synaptic proteins observed in differentiated CTX0E16
neurons and the presence of both filopodia and dendritic
spines, strongly indicate that differentiated CTX0E16 neu-
rons are capable of forming putative synapses.
CTX0E16 neurons exhibit morphological plasticity in
response to depolarisation
Early in development, the primary shape of a neuron
and the identity of the emerging neurites as an axon or
dendrites are progressively established. The regulated
growth and arborisation of dendritic and axonal pro-
cesses are critical to neural circuit formation, synapse
formation and synaptic input processing [43, 53, 54]. De-
veloping neurons are highly plastic and undergo modifi-
cations altering the branching pattern of neurites in
response to physiological and pathological changes
[43, 44, 53, 54]. It is now well-established that neuronal
activity is a crucial modulator of neurodevelopment
[43, 44, 53], and has a profound effect on neurite
outgrowth as well as on dendritic and axonal forma-
tion and branching [44, 53, 54]. Interestingly, previous
research has shown that prolonged depolarisation of
neurons differentiated from human iPSCs results in an
increase in the length of neurites via a Ca2+ -dependent
mechanism [55]. Although our data indicated that differ-
entiated CTX0E16 neurons expressed putative synapses,
and exhibited functional responses to stimulation with a
range of neurotransmitters, we questioned whether ma-
nipulating neuronal activity could regulate neurite out-
growth in these cells. This was achieved using a well-
established protocol to induce neuronal depolarisation
[55]: DD 15 GFP-expressing CTX0E16 neurons were ex-
posed to control media, 30 nM NaCl (osmotic control) or
30 mM KCl for 7 hours, and the average length of neurites
measured. This revealed that exposure to 30 mM KCl in-
duced an increase of approximately 35 % in the average
length of neurites compared to control or 30 mM NaCl
Fig. 7 CTX0E16 neurons express pre- and post-synaptic proteins. a-e In differentiation day (DD) 35 CTX0E16 neurons, puncta for the post-synaptic
proteins PSD-95 (a), GluA1 (b), GluA2 (c), GluN1 (d) and gephyrin (e) were observed along MAP2-positive dendrites (red arrows). f-j The excitatory
pre-synaptic proteins bassoon (f), synapsin1 (g), VGlut1 (h), and the inhibitory pre-synaptic proteins VGAT (i) and GAD65/67 (j) were observed in
punctate structures, either along or juxtaposed along MAP2-positive dendrites. Scale bars for a-j are 5 μm
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Fig. 8 (See legend on next page.)
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conditions (average neurite length (μm): control, 20.46
μm ± 1.76 μm; 30 mM NaCl, 21.03μm ± 1.20 μm; 30
mM KCl, 31.95μm ± 6.02 μm; n = 12−22 cells,
ANOVA, p <0.05; Fig. 8g, h). These data, taken to-
gether with the functional assays, strongly suggest that
CTX0E16 neurons display the characteristics of young
glutamatergic neurons that exhibit the functional char-
acteristics of a developing synaptic network in vitro.
Conclusion
The ability to model both normal and aberrant neurode-
velopment in human neurons holds great potential for
dissecting the underlying basic and disease-relevant
mechanisms. Moreover, it provides another avenue for
the discovery and screening of novel therapeutic mole-
cules. Until recently a major challenge has been to effi-
ciently produce a cost-effective and renewable source of
cells that can reliably generate a defined set of neuronal
cell types. Here we report that differentiation of the con-
ditionally immortalised cortical hNPC line, CTX0E16,
results predominately in the generation of glutamatergic
neurons. We demonstrate that differentiated CTX0E16
neurons retain a cortical identity, supported by their
gene profile and expression of a range of glutamatergic
and cortical markers. In addition, differentiated CTX0E16
cells form polarised neurons, and exhibit a cellular
morphology typical of pyramidal neurons previously ob-
served in vitro [17, 26, 27]. Furthermore, our data indicate
that differentiated CTX0E16 neurons express a range of
neurotransmitter receptor and signalling proteins con-
sistent with the generation of young maturing neurons.
Functional mobilisation of Ca2+ transients and activa-
tion of ERK1/2 signalling pathways were observed in re-
sponse to neurotransmitter receptor activation, indicating
that CTX0E16 cells generated functional neurons. An im-
portant question to consider is whether the subsequently
generated neurons closely resemble those found in vivo
and if they develop functional neuronal characteristics
including action potentials and synaptic connections. We
have addressed these questions using several different
strategies. Indeed, differentiated CTX0E16 neurons dis-
played the hallmarks of putative synapse formation and
neuronal activity, as demonstrated by spontaneous Ca2+
transients, electrophysiological recordings of action poten-
tials and EPSCs and the regulation of neuronal morph-
ology in response to physiological stimuli. Collectively,
these data demonstrate that CTX0E16 neurons are an
ideal platform from which to investigate both basic and
pathological mechanisms associated with neurodevelop-
mental disorders.
Many neurodevelopmental disorders display deficits in
cortical neurons. In particular, morphological and func-
tional properties of excitatory (glutamatergic) projection
neurons in the cortex have been strongly implicated in
disorders such as autism spectrum disorders (ASDs) and
schizophrenia [56]. While animal models have advanced
our understanding of the mechanisms that underlie
these disorders, many aspects of these diseases remain
unknown. Moreover, current rates of conversion of pre-
clinical investigation and drug discovery have in the
most part failed to deliver [57]. One approach that has
been suggested to overcome such shortcomings has been
to use human neurons. Indeed, several cellular models
to address this have been put forward, including ESCs,
iPSCs and immortalised NSCs and NPCs [1–5, 21]. Dif-
ficulties in obtaining tissue for ESCs in many cases hin-
der the use of these cells as a cellular model. Similarly,
the generation of appropriate control and patient iPSCs
and differentiation of these cells into distinct neuronal
lineages is both time-consuming and costly. On the
other hand, immortalised hNSC and hNPCs represent a
potentially unlimited source of cells that can generate
defined neural cell types [2–5]. However, in order for us
to realise the utility of such cells it is critical for us to
fully characterise the lineage and basic characteristics of
these cells lines. Already several groups have used
hNPCs to investigate the complex mechanisms underlying
neurodevelopmental disorders. These include studies on
cortisol and stress neurons derived from hippocampal
neurons [18], DISC1 loss of function in a cortical hNPC
(See figure on previous page.)
Fig. 8 Differentiated CTX0E16 neurons display hallmarks of putative synapses and respond to activity-dependent stimulation. a-c Representative
confocal images of differentiation day (DD) 35 CTX0E16 neurons immunostained for MAP2, PSD-95 and either bassoon (a), synapsin 1 (b) or VGAT
(c). As previously observed, all synaptic proteins display punctate distribution along dendrites. In addition, a subset of PSD-95 puncta co-localised
with all three pre-synaptic proteins (red arrow), indicating the presence of putative synapses; co-localisation is seen as white puncta. Not all
pre-synaptic puncta co-localised with PSD-95 (white open arrowheads), suggesting that synaptogenesis was ongoing. d, e Representative confocal
images of a distal dendrite of green fluorescent protein (GFP)-expressing ) CTX0E16 neurons (DD 35). Examination of dendrites revealed the presence
of filopodia and dendritic spine-like structures, indicative of ongoing synaptogenesis. Yellow boxes indicate region used in high magnification in inset.
f Western blotting of CTX0E16 neurons at different stages of differentiation demonstrate an increase in PSD-95 with maturation, consistent with an
increase in synaptogenesis. Rat ctx, whole-cell lysate taken from rat cortex. g Representative binary images of GFP-expressing CTX0E16 neurons (DD
15) following treatment with control conditions (vehicle or osmotic control (30 nM NaCl)) or activity-dependent stimulation with 30 nM KCl for 7 hours.
h Measurement of average neurite length in response to stimulation demonstrates that activity-dependent stimulation results in an increase in average
neurite length; n = 14–22 neurons from 3–5 independent experiments carried out in triplicate; error bars represent SEM; *p <0.05 (one way analysis of
variance with Tukey post hoc analysis). Scale bars for a-e are 5 μm; d and e inset, 1 μm; g, 50 μm
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model with implication for neuropsychiatric diseases [58],
and knockdown of the schizophrenia and bipolar suscepti-
bility gene, ZNF804a in a cortical hNPC line [20]. Based
on our immunohistochemical and functional characterisa-
tion of differentiated CTX0E16 neurons, we feel that this
hNPC line represents an ideal platform from which to in-
vestigate the development of human cortical neurons, and
how such mechanisms may be perturbed during the early
stages of pathogenesis of a range of neurodevelopmental
disorders. Moreover, these cells represent an alternative
cell model that has the potential to be scaled up for use in
medium- and high-throughput screens.
Additional file
Additional file 1: Figure S1. Expression profile of undifferentiated and
differentiated (DD28) CTX0E16 cells. Undifferentiated CTX0E16 cells express
a range of neurotransmitter receptors, signalling and disease-associated
proteins, which are upregulated during differentiation, as determined by
RT-PCR; n = 3 independent experiments carried out in triplicate. Table S1
List of antibodies used in study. Table S2 List and description of primers
used in RT-PCR and q-PCR experiments. (PDF 181 kb)
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